. "Appendix A National Academies' Guidelines for Human Embryonic Stem Cell Research, Amended as of February 2007." 2007 Amendments to the National Academies' Guidelines for Human Embryonic Stem Cell Research. Washington, DC: The National Academies Press, 2007.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
2007 Amendments The National Academies’ Guidelines for Human Embryonic Stem Cell Research
and should have the resources needed to coordinate the management of the various other reviews required for a particular protocol. A preexisting committee could serve the functions of the ESCRO committee provided that it has the recommended expertise and representation to perform the various roles described in this report. For example, an institution might elect to constitute an ESCRO committee from among some members of an IRB. But the ESCRO committee should not be a subcommittee of the IRB, as its responsibilities extend beyond human subject protections. Furthermore, much hES cell research does not require IRB review. The ESCRO committee should
provide oversight over all issues related to derivation and use of hES cell lines,
review and approve the scientific merit of research protocols,
review compliance of all in-house hES cell research with all relevant regulations and these guidelines,
maintain registries of hES cell research conducted at the institution and hES cell lines derived or imported by institutional investigators, and
facilitate education of investigators involved in hES cell research.
An institution that uses an external ESCRO committee should neverthelessensure that the registry and educational functions of an internal ESCROcommittee are carried out by the external ESCRO committee on its behalf orinternally by other administrative units.
2.1For projects that involve more than one institution, review of the scientific merit, justification, and compliance status of the research may be carried out by a single ESCRO committee if all participating institutions agreeto accept the results of the review.
3.0 PROCUREMENT OF GAMETES, BLASTOCYSTS, OR CELLSFOR hES GENERATION
3.1 An IRB, as described in federal regulations at 45 CFR 46.107, should review the procurement of all gametes, blastocysts, or somatic cells for the purpose of generating new hES cell lines, including the procurement of blastocysts in excess of clinical need from infertility clinics, blastocysts made through IVF specifically for research purposes, and oocytes, sperm, and